Does the pathological factor in amyotrophic lateral sclerosis (ALS) damage also astrocytes?

Area of Science:

• Neuroscience
• Neuropathology

Background:

• Glial fibrillary acidic protein (GFAP) immunocytochemistry enhances astrocyte reactivity assessment in central nervous system (CNS) diseases.
• Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting motor neurons.
• Limited research exists on reactive astroglia within the spinal cord in ALS.

Purpose of the Study:

• To examine astrocyte reactivity in the cervical, thoracic, and lumbar spinal cords of sporadic ALS patients.
• To correlate glial changes with neuronal degeneration in ALS.

Main Methods:

• Histopathological examination of spinal cord sections from 11 sporadic ALS patients.
• Staining techniques included hematoxylin and eosin, Kluver-Barrera, and GFAP immunocytochemistry.
• Morphological analysis of neurons and astrocytes in the anterior horns and white matter.

Main Results:

• Observed nerve cell loss in the anterior horn, neuronal pigmentary degeneration, and myelin pallor in all ALS cases.
• Tissue rarefaction in the anterior horn was noted in some cases.
• A subset of cases showed intense neuronal changes with a weak astrocyte GFAP reaction.

Conclusions:

• Significant neuronal and glial alterations occur in the spinal cord in ALS.
• The observed discrepancy between severe neuronal damage and mild astrocyte reactivity suggests a potential unknown pathological factor.
• This factor may simultaneously affect anterior horn neurons and astrocytes in ALS.